Gene expression signatures for anti-glioma therapy with Ad-SGE-REIC and bevacizumab. Gene expression signatures for anti-glioma therapy with Ad-SGE-REIC and bevacizumab

We investigated the gene expression profile of tumor-bearing mouse brain treated with PBS(control), Ad-SGE-REIC(SGE), or combination of Ad-SGE-REIC and bevacizumab (SGE+BEV). Overall design: Gene expression in mouse brain treated with PBS, Ad-SGE-REIC, Ad-SGE-REIC and bevacizumab were evaluated